The Biotech Academy Awards
Motley Fool - USA
The prologue to this drama actually dates back to 2005 when partners "voluntarily" pulled their multiple sclerosis drug Tysabri from the market over safety ...

Street eyeing Biogen`s Tysabri
Monsters and Critics.com - Glasgow,UK
Analysts are lukewarm on the company predominantly due to concerns about the future of Biogen`s multiple sclerosis drug Tysabri. ...
See all stories on this topic

Elan Ends Up As Biogen Revives Tysabri
Houston Chronicle - Houston,TX,USA
NEW YORK — American Depositary Shares of Irish biopharmaceutical developer Elan Corp. rose Thursday after Biogen Idec Inc. said it will reintroduce Tysabri, ...
See all stories on this topic